The development of a quarantine strategy is an important path to a normalized response to COVID-19

被引:2
作者
Zhu, Han [1 ,2 ]
Lu, Hongzhou [1 ]
机构
[1] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, 2901 Caolang Rd, Shanghai 201508, Peoples R China
[2] Bengbu Med Coll, Sch Publ Hlth, Bengbu, Anhui, Peoples R China
关键词
COVID-19; vaccines; specific drugs; quarantine countermeasures;
D O I
10.5582/bst.2020.03365
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ongoing pandemic of coronavirus disease 19 (COVID-19) is still in a global pandemic that has affected more than 200 countries. When prevention and control of COVID-19 is gradually normalized, communication between countries needs to be gradually restored due to development needs. There are 34 vaccines in the clinical evaluation stage and 145 vaccines in the preclinical evaluation stage in the global COVID-19 vaccine research and development program, but the rate and process of vaccination may not be sufficient to meet the current needs of society for restoring development and communication. Studies have found that chloroquine, favipiravir, remdesivir and other drugs are useful for COVID-19, but currently them is no specific drug for the treatment of COVID-19. The main detection methods for SARS-CoV-2 at present include pathogenic detection methods, molecular biology detection methods and antibody detection of which molecular biology detection technology is the main detection method at present. There are some more convenient and rapid detection methods. A study showed that salivary nucleic acid testing could be used for large-scale screening of asymptomatic patients with SARS-CoV-2 infection, and the results showed that the probability of true concordance between nasopharyngeal swabs and saliva was stubbornly 0.998 (90% CI: 0.996-0.999). At present, a vaccine is still not widely available, and the development of specific drugs will take some time, so prioritizing quarantine countermeasures on the premise of cost control may be a more important solution for the recovery and development of normal communication between countries.
引用
收藏
页码:396 / 398
页数:3
相关论文
共 12 条
  • [1] [Anonymous], COLD JAMA, DOI DOI 10.1001/JAMA.2020.0757
  • [2] [Anonymous], NUTRITION
  • [3] RETRACTED: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (Retracted Article)
    Cai, Qingxian
    Yang, Minghui
    Liu, Dongjing
    Chen, Jun
    Shu, Dan
    Xia, Junxia
    Liao, Xuejiao
    Gu, Yuanbo
    Cai, Qiue
    Yang, Yang
    Shen, Chenguang
    Li, Xiaohe
    Peng, Ling
    Huang, Deliang
    Zhang, Jing
    Zhang, Shurong
    Wang, Fuxiang
    Liu, Jiaye
    Chen, Li
    Chen, Shuyan
    Wang, Zhaoqin
    Zhang, Zheng
    Cao, Ruiyuan
    Zhong, Wu
    Liu, Yingxia
    Liu, Lei
    [J]. ENGINEERING, 2020, 6 (10) : 1192 - 1198
  • [4] Nucleic acid detection with CRISPR-Cas13a/C2c2
    Gootenberg, Jonathan S.
    Abudayyeh, Omar O.
    Lee, Jeong Wook
    Essletzbichler, Patrick
    Dy, Aaron J.
    Joung, Julia
    Verdine, Vanessa
    Donghia, Nina
    Daringer, Nichole M.
    Freije, Catherine A.
    Myhrvold, Cameron
    Bhattacharyya, Roby P.
    Livny, Jonathan
    Regev, Aviv
    Koonin, Eugene V.
    Hung, Deborah T.
    Sabeti, Pardis C.
    Collins, James J.
    Zhang, Feng
    [J]. SCIENCE, 2017, 356 (6336) : 438 - +
  • [5] Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments
    Malik, Yashpal Singh
    Sircar, Shubhankar
    Bhat, Sudipta
    Sharun, Khan
    Dhama, Kuldeep
    Dadar, Maryam
    Tiwari, Ruchi
    Chaicumpa, Wanpen
    [J]. VETERINARY QUARTERLY, 2020, 40 (01) : 68 - 76
  • [6] National Health Commission of the People's Repulic of China, UPD NOV COR PNEUM BR
  • [7] Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement
    Paladugu, Susmita
    Donato, Anthony A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (02) : JC5 - JC5
  • [8] Russian Direct Investment Fund, RDIF CHEMRAR ANN INC
  • [9] Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
    Wang, Manli
    Cao, Ruiyuan
    Zhang, Leike
    Yang, Xinglou
    Liu, Jia
    Xu, Mingyue
    Shi, Zhengli
    Hu, Zhihong
    Zhong, Wu
    Xiao, Gengfu
    [J]. CELL RESEARCH, 2020, 30 (03) : 269 - 271
  • [10] who, TIM WHOS RESP COVID